For breast cancer, there is an overwhelming amount of data suggesting that a variety of known factors influencing survival (i.e., stage at diagnosis, treatment protocol, the status of hormonal receptors, lifestyle, comorbidities, and participation in screening) do not fully explain the socioeconomic gap [34]. This evidence concerns the gene NR4A1 and breast carcinoma.